Chiasso, Switzerland, March 2nd, 2026 –FarmaMondo Group is proud to announce the opening of its new office in Mumbai, India- marking their 13th global location across six key regions.
This expansion represents a significant milestone in the company’s ongoing commitment to bringing innovative, life-changing medicines to patients in emerging markets.
With the India regional office now fully operational, FarmaMondo commences an exciting new chapter to enhance direct access to innovative, specialty, and rare disease therapies for patients and their healthcare professionals across India and South Asia.
Says Mr. Sudheendra Kulkarni, Regional Managing Director, India & South Asia:
“Establishing our India hub is a game-changer for FarmaMondo’s presence across the region, enabling expanded and faster access to innovative medicines where unmet needs are greatest, bringing market specific access solutions is our purpose.”
Says Dr. Alok Dev, Medical Access Director, India and South Asia: “India faces profound challenges in rare diseases, with over 70 million people potentially affected, yet the majority remain undiagnosed or untreated. Our mission at FarmaMondo is to drive awareness, support diagnoses, and expand access to truly life changing specialty medicines.”
Yaron Spigel, CEO, FarmaMondo Group adds: “This expansion underscores FarmaMondo’s unwavering commitment to supporting underserved patients, wherever they are and further deepens our partnerships with global biotech and pharma innovators to unlock access to emerging markets and the patients within.
I am delighted to welcome Sudheendra and the entire team to the FarmaMondo Group, bringing deep expertise in specialty pharmaceuticals, market access, and commercial execution, positioning FarmaMondo India to build on our already strong international presence.”
****
About FarmaMondo Group:
Founded in 1915, FarmaMondo is a Swiss-headquartered pharmaceutical group with 13 international affiliates. The company’s full-service commercialization model enables biopharma innovators to bring innovative and specialty medicines to underserved patients in emerging markets. With a proven track record of commercializing more than 50 assets across 40+ countries, FarmaMondo is dedicated to delivering life-changing therapies to patients worldwide—without compromise.
For more information about FarmaMondo, please visit: www.farmamondo.com
FarmaMondo general and partner inquiries:
For general inquiries please contact: info@farmamondo.com
For India related inquiries please contact: info.india@farmamondo.com
For Business Development inquiries please contact: partnering@farmamondo.com
